intragastric acidity Latest Research Papers

pH-Responsive Au(i)-disulfide nanoparticles with tunable aggregation-induced emission for monitoring intragastric acidity

Chemical Science ◽

10.1039/d0sc01843k ◽

2020 ◽

Vol 11 (25) ◽

pp. 6472-6478 ◽

Cited By ~ 1

Author(s):

Jianxing Wang ◽

Jie Li ◽

Ying Li ◽

Zhijun Zhang ◽

Lei Wang ◽

...

Keyword(s):

Luminescent Probe ◽

Ph Responsive ◽

Intragastric Acidity ◽

Aggregation Induced Emission

The water-stable and pH-responsive Au(i)-disulfide NPs serve as a luminescent probe for monitoring intragastric acidity in an acid-suppressed therapy.

Download Full-text

THE EFFECT OF FOOD ON CLINICAL SYMPTOMS AND INTRAGASTRIC ACIDITY IN DUODENAL ULCER

The Clinician ◽

10.17650/1818-8338-2016-10-4-50-54 ◽

2017 ◽

Vol 11 (1) ◽

pp. 50-54

Author(s):

A. I. Koveshnikov ◽

I. Yu. Kolesnikova

Keyword(s):

Duodenal Ulcer ◽

Clinical Symptoms ◽

Intragastric Acidity ◽

Effect Of Food

Download Full-text

PWE-071 The Majority of H. Pylori Infected Subjects Have Reduced Intragastric Acidity and Parietal Cell Density which is Most Marked Close to The Gastroesophageal Junction: Abstract PWE-071 Table 1

Gut ◽

10.1136/gutjnl-2016-312388.316 ◽

2016 ◽

Vol 65 (Suppl 1) ◽

pp. A172.2-A173

Author(s):

D Mitchell ◽

M Derakhshan ◽

A Wirz ◽

C Orange ◽

D Hughes ◽

...

Keyword(s):

Cell Density ◽

Parietal Cell ◽

Gastroesophageal Junction ◽

Intragastric Acidity ◽

H Pylori

Download Full-text

619 In the Healthy Population, H. pylori Infected Subjects Have Less Intragastric Acidity and This Is Most Marked Close to the Gastroesophageal Junction

Gastroenterology ◽

10.1016/s0016-5085(16)30533-9 ◽

2016 ◽

Vol 150 (4) ◽

pp. S127

Author(s):

David Mitchell ◽

Mohammad H. Derakhshan ◽

Angela Wirz ◽

Stuart Ballantyne ◽

Alexander J. Weir ◽

...

Keyword(s):

Gastroesophageal Junction ◽

Healthy Population ◽

Intragastric Acidity ◽

H Pylori

Download Full-text

Faculty of 1000 evaluation for Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718016185.793478839 ◽

2013 ◽

Author(s):

Ian Beales

Keyword(s):

Crossover Study ◽

Phase 1 ◽

Immediate Release ◽

Intragastric Acidity ◽

Enteric Coated Aspirin ◽

Enteric Coated

Download Full-text

Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: A randomized crossover study

Clinics and Research in Hepatology and Gastroenterology ◽

10.1016/j.clinre.2012.07.010 ◽

2013 ◽

Vol 37 (3) ◽

pp. 296-301 ◽

Cited By ~ 2

Author(s):

Sachio Hata ◽

Makoto Arai ◽

Daisuke Maruoka ◽

Takeshi Tanaka ◽

Tomoaki Matsumura ◽

...

Keyword(s):

Crossover Study ◽

Proton Pump Inhibitors ◽

Proton Pump ◽

Low Dose ◽

Intragastric Acidity ◽

Randomized Crossover Study

Download Full-text

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12340 ◽

2013 ◽

Vol 38 (1) ◽

pp. 62-71 ◽

Cited By ~ 10

Author(s):

P. B. Miner ◽

J. G. Fort ◽

Y. Zhang

Keyword(s):

Crossover Study ◽

Phase 1 ◽

Immediate Release ◽

Intragastric Acidity ◽

Enteric Coated Aspirin ◽

Enteric Coated

Download Full-text

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

Alimentary Pharmacology & Therapeutics ◽

10.1111/apt.12014 ◽

2012 ◽

Vol 36 (7) ◽

pp. 627-634 ◽

Cited By ~ 31

Author(s):

M. Sugimoto ◽

N. Shirai ◽

M. Nishino ◽

C. Kodaira ◽

T. Uotani ◽

...

Keyword(s):

Cyp2c19 Genotype ◽

Intragastric Acidity

Download Full-text

Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: A randomized, open-labeled, two-way crossover study

Medical Science Monitor ◽

10.12659/msm.882468 ◽

2012 ◽

Vol 18 (2) ◽

pp. CR125-CR130

Author(s):

Xian-Bao Zhan ◽

Xiao-Rong Guo ◽

Zhao-Shen Li ◽

Yan-Fang Gong ◽

Jun Gao ◽

...

Keyword(s):

Crossover Study ◽

Inhibitory Effects ◽

Intragastric Acidity ◽

Healthy Chinese

Download Full-text

Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping

Alimentary Pharmacology & Therapeutics ◽

10.1111/j.1365-2036.2010.04544.x ◽

2010 ◽

Vol 33 (4) ◽

pp. 471-476 ◽

Cited By ~ 12

Author(s):

S. Miehlke ◽

S. Löbe ◽

A. Madisch ◽

E. Kuhlisch ◽

M. Laass ◽

...

Keyword(s):

Crossover Study ◽

Intragastric Acidity

Download Full-text

intragastric acidity
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

pH-Responsive Au(i)-disulfide nanoparticles with tunable aggregation-induced emission for monitoring intragastric acidity

THE EFFECT OF FOOD ON CLINICAL SYMPTOMS AND INTRAGASTRIC ACIDITY IN DUODENAL ULCER

PWE-071 The Majority of H. Pylori Infected Subjects Have Reduced Intragastric Acidity and Parietal Cell Density which is Most Marked Close to The Gastroesophageal Junction: Abstract PWE-071 Table 1

619 In the Healthy Population, H. pylori Infected Subjects Have Less Intragastric Acidity and This Is Most Marked Close to the Gastroesophageal Junction

Faculty of 1000 evaluation for Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.

Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: A randomized crossover study

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: A randomized, open-labeled, two-way crossover study

Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping

Export Citation Format

intragastric acidityRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

pH-Responsive Au(i)-disulfide nanoparticles with tunable aggregation-induced emission for monitoring intragastric acidity

THE EFFECT OF FOOD ON CLINICAL SYMPTOMS AND INTRAGASTRIC ACIDITY IN DUODENAL ULCER

PWE-071 The Majority of H. Pylori Infected Subjects Have Reduced Intragastric Acidity and Parietal Cell Density which is Most Marked Close to The Gastroesophageal Junction: Abstract PWE-071 Table 1

619 In the Healthy Population, H. pylori Infected Subjects Have Less Intragastric Acidity and This Is Most Marked Close to the Gastroesophageal Junction

Faculty of 1000 evaluation for Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.

Intragastric acidity during the first day following administration of low-dose proton pump inhibitors: A randomized crossover study

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study

Rabeprazole 10 mg q.d.s. decreases 24-h intragastric acidity significantly more than rabeprazole 20 mg b.d. or 40 mg o.m., overcoming CYP2C19 genotype

Inhibitory effects of intravenous lansoprazole 30 mg and pantoprazole 40 mg twice daily on intragastric acidity in healthy Chinese volunteers: A randomized, open-labeled, two-way crossover study

Intragastric acidity during administration of generic omeprazole or esomeprazole - a randomised, two-way crossover study including CYP2C19 genotyping

intragastric acidity
Recently Published Documents